EW
GBT

Evoke Wealth’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Evoke Wealth’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32
Closed -$1K – 1221
2020
Q4 		$1K Hold
32
– – ﹤0.01% 1017
2020
Q3 		$2K Hold
32
– – ﹤0.01% 883
2020
Q2 		$2K Hold
32
– – ﹤0.01% 921
2020
Q1 		$1.64K Sell
32
-124
-79% -$8.31K ﹤0.01% 839
2019
Q4 		$12.4K Hold
156
– – ﹤0.01% 693
2019
Q3 		$7.57K Buy
+156
New +$8.13K ﹤0.01% 893

Other funds holding GBT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Evoke Wealth's GBT Position: Q1 2021 in Review

Evoke Wealth sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2021, closing a stake of 32 shares — an estimated $1K sold.

Evoke Wealth first reported a position in GBT in Q3 2019 and held it in 6 quarters. The position peaked at $12.4K in Q4 2019. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

  • Evoke Wealth reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Evoke Wealth sold 32 Global Blood Therapeutics, Inc. shares in Q1 2021, an estimated $1K.
  • Evoke Wealth first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 6 quarters.
  • Evoke Wealth's Global Blood Therapeutics, Inc. position peaked at $12.4K in Q4 2019.
  • 214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on Evoke Wealth's 13F filing for Q1 2021, filed 13 May 2021.